| Mrs Lisa Nicole Odom, | |
|
1090 W Park Pl, Coeur D Alene, ID 83814-2785 | |
| (208) 215-2005 | |
| (844) 807-3782 |
| Full Name | Mrs Lisa Nicole Odom |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1090 W Park Pl, Coeur D Alene, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598007668 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | M-13382 (Idaho) | Primary |
| Entity Name | Kootenai Health, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235288655 PECOS PAC ID: 4789641598 Enrollment ID: O20041214000230 |
News Archive
The drug crizotinib (trade name: Xalkori) has been available since 2012 for patients with advanced non-small cell lung cancer (bronchial carcinoma) who have a high activity of the enzyme anaplastic lymphoma kinase (ALK) and have already received another treatment. In November 2015, the approval was extended to first-line treatment.
Collaborating scientists in Boston and North Carolina have found that a particular gene can block key steps of the lung cancer process in mice.
Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).
New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain.
› Verified 1 days ago
| Entity Name | Dirne Health Centers, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285686477 PECOS PAC ID: 2466353354 Enrollment ID: O20050303001041 |
News Archive
The drug crizotinib (trade name: Xalkori) has been available since 2012 for patients with advanced non-small cell lung cancer (bronchial carcinoma) who have a high activity of the enzyme anaplastic lymphoma kinase (ALK) and have already received another treatment. In November 2015, the approval was extended to first-line treatment.
Collaborating scientists in Boston and North Carolina have found that a particular gene can block key steps of the lung cancer process in mice.
Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).
New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain.
› Verified 1 days ago
| Entity Name | Kootenai Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174661151 PECOS PAC ID: 1355792276 Enrollment ID: O20240111003252 |
News Archive
The drug crizotinib (trade name: Xalkori) has been available since 2012 for patients with advanced non-small cell lung cancer (bronchial carcinoma) who have a high activity of the enzyme anaplastic lymphoma kinase (ALK) and have already received another treatment. In November 2015, the approval was extended to first-line treatment.
Collaborating scientists in Boston and North Carolina have found that a particular gene can block key steps of the lung cancer process in mice.
Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).
New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lisa Nicole Odom, Po Box 1387, Hayden, ID 83835-1387 Ph: (208) 415-0299 | Mrs Lisa Nicole Odom, 1090 W Park Pl, Coeur D Alene, ID 83814-2785 Ph: (208) 215-2005 |
News Archive
The drug crizotinib (trade name: Xalkori) has been available since 2012 for patients with advanced non-small cell lung cancer (bronchial carcinoma) who have a high activity of the enzyme anaplastic lymphoma kinase (ALK) and have already received another treatment. In November 2015, the approval was extended to first-line treatment.
Collaborating scientists in Boston and North Carolina have found that a particular gene can block key steps of the lung cancer process in mice.
Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).
New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain.
› Verified 1 days ago
Dr. Thomas R Rau, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 W Ironwood Dr, Suite 155, Coeur D Alene, ID 83814 Phone: 208-667-0585 Fax: 208-667-0876 | |
Terence Earl Neff, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 W Ironwood Dr, Suite 155, Coeur D Alene, ID 83814 Phone: 208-667-0585 Fax: 208-667-0876 | |
Dr. Brook Yuknis Lang, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2003 Kootenai Health Way, Coeur D Alene, ID 83814 Phone: 208-625-5185 Fax: 208-625-5892 | |
Dr. Mary Jo Shaw, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 W Ironwood Dr, Suite 155, Coeur D Alene, ID 83814 Phone: 208-667-0585 Fax: 208-667-0876 | |
Dr. Beth Ann Martin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2003 Kootenai Health Way, Coeur D Alene, ID 83814 Phone: 208-625-6446 Fax: 208-625-5931 | |
Dr. Cheri Kathleen Savage, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 W Ironwood Dr, Suite 155, Coeur D Alene, ID 83814 Phone: 208-667-0585 Fax: 208-667-0876 | |
Dr. Rene Chalom, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2003 Kootenai Health Way, Coeur D Alene, ID 83814 Phone: 208-625-5930 Fax: 208-625-5931 |